Cellular reprogramming
- PMID: 24492711
- PMCID: PMC3941237
- DOI: 10.1101/cshperspect.a018606
Cellular reprogramming
Abstract
Nuclear reprogramming technology was first established more than 50 years ago. It can rejuvenate somatic cells by erasing the epigenetic memories and reconstructing a new pluripotent order. The recent discovery reviewed here that induced pluripotency can be achieved by a small set of transcription factors has opened up unprecedented opportunities in the pharmaceutical industry, the clinic, and laboratories. This technology allows us to access pathological studies by using patient-specific induced pluripotent stem (iPS) cells. In addition, iPS cells are also expected to be a rising star for regenerative medicine, as sources of transplantation therapy.
Figures

References
-
- Davis R, Weintraub H, Lassar AB 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51: 987–1000 - PubMed
-
- Gurdon JB, Elsdale TR, Fischber M 1958. Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature 182: 64–65 - PubMed
-
- Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T 2001. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11: 1553–1558 - PubMed
-
- Takahashi K, Yamanaka S 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676 - PubMed
-
- Waddington CH 1957. The strategy of the genes. Allen & Unwin, London
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources